- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07701694
Functional Evaluation in Patients With Urea Cycle Disorders (UCD) During a Driving Task
Cognitive and Motor Function Examination in Patients With Urea Cycle Disorders (UCD) During a Driving Task Using Functional Near Infrared Spectroscopy (fNIRS)
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Primary Objective
- To use fNIRS to study brain functional behavior in subjects with UCD by measuring the changes in HbO, HbR and HbT concentrations versus healthy control volunteers during the baseline driving task on the left and right prefrontal cortex (LPFC, RPFC).
Secondary Objective
- To include other cortical regions such as temporal and occipital regions, to investigate the neurocognitive changes in these regions which may or may not change with driving. Thus, we will measure changes in HbO, HbR and HbT concentrations during the baseline driving task in four more brain regions (left and right parietal and occipital regions, LPA, RPA, LOL, ROL).
This is a non-therapeutic, non-interventional study in which brain fNIRS (functional near-infrared spectroscopy) measures will be compared under simulated driving conditions between patients with UCD vs. age and sex-matched control participants.
Participants who agree to participate will have Information about their medical history collected, have a basic neurological exam and answer questions about their health, diet, and driving habits. They will complete some simple thinking and memory tests. These tests will help investigators understand skills like memory, attention, and problem-solving. Participants will also wear a soft cap with small sensors called an fNIRS (functional near-infrared spectroscopy) device while they complete a driving simulator activity. This cap is noninvasive and measures how the brain uses oxygen while they drive in the simulator.
All study activities will be completed on the day of enrollment.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Jean Laboe, RN
- Telefonnummer: 901-595-1693
- E-post: jean.laboe@stjude.org
Studiesteder
-
-
Tennessee
-
Memphis, Tennessee, Forente stater, 38105
- Rekruttering
- St. Jude Children's Research Hospital
-
Ta kontakt med:
- Jean Laboe, RN
- Telefonnummer: 901-595-1693
- E-post: jean.laboe@stjude.org
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Individuals 16 to 40 years with molecular or biochemical confirmation of a urea cycle disorder.
- Healthy individuals will serve as an age and sex matched comparison group. Active driver's license for at least 6 months
- Read and understand English. as the tasks have not been validated in other languages
- IQ >=70.
Exclusion Criteria:
- Skin disease that affects the scalp
- Past or present vascular disease
- Head trauma with loss of consciousness in the last year or evidence of cognitive impairment due to and persisting after head trauma
- Motor movement disorder which may cause excessive movement or impede use of the steering wheel and/or pedal
- Premature birth or birth before 32 weeks of gestation
- The participant is taking a stimulant or antidepressant
- Allergy to any component of the device, although expected to be rare
- History of psychosis
- Self-reported motion or cyber sickness
- Self-reported illicit substance use
- Vision disorder
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
UCD group
Participants with urea cycle disorders (UCD) who meet the Eligibility Criteria and consent to participate
|
|
Control group
Healthy controls who meet the Eligibility Criteria and consent to participate
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Oxyhemoglobin (HbO), Deoxyhemoglobin (HbR) and Total Hemoglobin (HbT) concentrations in the right and left prefrontal cortex in participants with urea cycle disorders (UCD) compared to healthy control volunteers
Tidsramme: Day 1, during driving simulator task
|
Investigators will compare prefrontal cortex hemoglobin concentrations during low cognitive load between patients with UCD and healthy age and sex matched control participants using functional near-infrared spectroscopy (fNIRS).
Mean values of hemoglobin concentration differences on the right and left prefrontal cortex between individuals, with and without UCD, during the low cognitive load task will be calculated and compared using two sample t-tests (for normally distributed data) or Wilcoxon rank sum tests (for nonnormally distributed data).
P values will be adjusted for multiple comparisons using the Bonferroni method.
|
Day 1, during driving simulator task
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in HbO, HbR and HbT concentrations in the left and right parietal and occipital brain regions in participants with urea cycle disorders (UCD) compared to healthy control volunteers
Tidsramme: Day 1, during driving simulator task
|
Investigators will compare left and right parietal and occipital regions hemoglobin concentrations during low cognitive load between patients with UCD and healthy age and sex matched control participants using functional near-infrared spectroscopy (fNIRS).
Mean values of hemoglobin concentration differences on the left and right parietal and occipital regions between individuals, with and without UCD, during the low cognitive load task will be calculated and compared using two sample t-tests (for normally distributed data) or Wilcoxon rank sum tests (for nonnormally distributed data).
P values will be adjusted for multiple comparisons using the Bonferroni method.
|
Day 1, during driving simulator task
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Andrea Gropman, M.D., St. Jude Children's Research Hospital
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Hjernesykdommer
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Metabolisme, medfødte feil
- Genetiske sykdommer, medfødte
- Metabolske sykdommer
- Hjernesykdommer, metabolske, medfødte
- Hjernesykdommer, metabolske
- Aminosyremetabolisme, medfødte feil
- Medfødte, arvelige og neonatale sykdommer og abnormiteter
- Ernæringsmessige og metabolske sykdommer
- Ureasyklusforstyrrelser, medfødt
Andre studie-ID-numre
- DRIVEUCD
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .